Clinical trials of HIV vaccines requires greater participation of women and adolescents, the WorldHealth Organization (WHO) said Tuesday in a press release. Experts attending a recently-concluded HIV vaccine trial conference in Lausanne, Switzerland, said studies show that women are at least twice as likely to become infected with HIV as their male counterparts.